EDGAR Filing Documents for 0001493152-20-011022

Form 8-K - Current report:

SEC Accession No. 0001493152-20-011022

Filing Date

2020-06-11

Accepted

2020-06-11 17:27:16

Documents

Period of Report

2020-06-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	185385
2		ex3-1.htm	EX-3.1	201646
3		ex3-2.htm	EX-3.2	202573
4		ex3-3.htm	EX-3.3	100254
5		ex3-4.htm	EX-3.4	100413
6		ex3-5.htm	EX-3.5	1708
7		ex4-1.htm	EX-4.1	100413
8		ex4-2.htm	EX-4.2	71228
9		ex10-1.htm	EX-10.1	80238
10		ex10-2.htm	EX-10.2	73511
11		ex10-3.htm	EX-10.3	55240
12		ex10-4.htm	EX-10.4	77027
13		ex10-5.htm	EX-10.5	49299
14		ex10-6.htm	EX-10.6	61813
15		ex99-1.htm	EX-99.1	14191
16		ex99-2.htm	EX-99.2	17668
17		ex3-5_001.jpg	GRAPHIC	492547
18		ex3-5_002.jpg	GRAPHIC	276134
	Complete submission text file	0001493152-20-011022.txt		2453265

Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820

Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555

OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)